Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 12/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974107 | 0.85 | CA2 (0.69) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL8974390 | 0.83 | PTGS2 (0.47) | PTGS2PTGS1 | |
| SCHEMBL8974499 | 0.82 | PTGS2 (0.61) | PTGS2PTGS1 | |
| SCHEMBL18876343 | 0.82 | PTGS2 (0.76) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL9117663 | 0.82 | PTGS2 (0.62) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL8974819 | 0.81 | PTGS2 (0.56) | PTGS2PTGS1 | |
| SCHEMBL9118177 | 0.80 | PTGS2 (0.56) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL9117783 | 0.80 | PTGS2 (0.56) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL6747283 | 0.78 | PTGS2 (0.41) | PTGS2PTGS1 | |
| SCHEMBL8487954 | 0.77 | PTGS2 (1.00) | PTGS2PTGS1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576339-A | Pyridyl substituted cyclopentadienes for the treatment of inflamation | HUANG HORNG-CHIH (US) | 1996-11-19 | — | — | US | disclosed |
| WO-1995030656-A1 | SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | disclosed |
| US-5418254-A | Side effect reduction | G. D. SEARLE & CO. (US) | 1995-05-23 | — | — | US | disclosed |